Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 817,600 | 446,200 | 1,137,000 | 441,500 | 94,500 |
| Marketable Securities | 1,890,100 | 1,087,100 | 248,600 | 107,100 | 29,200 |
| Receivables | 428,500 | 286,300 | 226,700 | 134,300 | 101,700 |
| Inventories | 234,700 | 119,800 | 70,700 | 45,200 | 45,400 |
| TOTAL | $3,424,800 | $1,969,400 | $1,699,500 | $744,700 | $280,000 |
| Non-Current Assets | |||||
| PPE Net | 515,300 | 321,300 | 183,100 | 145,600 | 109,400 |
| Intangibles | 40,700 | 18,600 | 18,700 | 12,100 | 11,300 |
| Other Non-Current Assets | 309,700 | 85,700 | 14,700 | 1,700 | 2,100 |
| TOTAL | $865,700 | $425,600 | $216,500 | $159,400 | $122,800 |
| Total Assets | $4,290,500 | $2,395,000 | $1,916,000 | $904,100 | $402,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 481,100 | 256,400 | 147,100 | 87,200 | 68,100 |
| Accrued Expenses | 114,300 | 88,500 | 72,400 | 48,500 | 33,400 |
| TOTAL | $614,100 | $360,200 | $222,400 | $138,900 | $102,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,667,200 | 1,059,700 | 1,010,300 | 327,600 | 0 |
| Deferred Revenues | 2,200 | 1,700 | 2,900 | 3,200 | 900 |
| Other Non-Current Liabilities | 182,700 | 92,500 | 20,000 | 18,200 | 16,600 |
| TOTAL | $1,849,900 | $1,152,200 | $1,030,300 | $345,800 | $16,600 |
| Total Liabilities | $2,464,000 | $1,512,400 | $1,252,700 | $484,700 | $119,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 384,709 | 366,377 | 360,007 | 347,989 | 339,260 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -202,100 | -695,700 | -798,900 | -671,800 | -621,000 |
| Other shareholders' equity | 3,200 | 2,300 | 1,500 | -2,600 | -1,000 |
| TOTAL | $1,826,500 | $882,600 | $663,300 | $419,400 | $283,800 |
| Total Liabilities And Equity | $4,290,500 | $2,395,000 | $1,916,000 | $904,100 | $402,800 |